UNICA IRIS Institutional Research Information System

ZIRANU, PINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 33.448
NA - Nord America 2.253
AS - Asia 1.425
SA - Sud America 230
AF - Africa 44
Totale 37.400
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 32.858
US - Stati Uniti d'America 2.176
SG - Singapore 627
CN - Cina 340
VN - Vietnam 178
BR - Brasile 173
SE - Svezia 151
DE - Germania 88
FR - Francia 72
GB - Regno Unito 69
IN - India 57
HK - Hong Kong 50
FI - Finlandia 48
CA - Canada 44
BD - Bangladesh 37
NL - Olanda 34
MX - Messico 23
ES - Italia 20
IE - Irlanda 20
IQ - Iraq 20
PL - Polonia 16
KR - Corea 15
AT - Austria 14
CO - Colombia 14
EC - Ecuador 14
TR - Turchia 14
UA - Ucraina 14
ZA - Sudafrica 13
JP - Giappone 12
AR - Argentina 11
MA - Marocco 10
PK - Pakistan 10
BE - Belgio 9
ID - Indonesia 8
RU - Federazione Russa 8
VE - Venezuela 7
IR - Iran 6
PH - Filippine 6
IL - Israele 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
KE - Kenya 4
KG - Kirghizistan 4
LT - Lituania 4
PE - Perù 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
BZ - Belize 3
CZ - Repubblica Ceca 3
KZ - Kazakistan 3
MK - Macedonia 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
LU - Lussemburgo 2
MU - Mauritius 2
MY - Malesia 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
Totale 37.400
Salva come PNG Salva come JPEG
Città #
Cagliari 31.409
Uta 1.181
Singapore 373
Ashburn 304
Dallas 239
San Jose 197
Fairfield 100
Boardman 97
Beijing 83
Nyköping 83
Chandler 78
Los Angeles 74
New York 61
Council Bluffs 59
Ho Chi Minh City 56
Houston 53
Seattle 52
Hong Kong 47
Santa Clara 42
Wilmington 42
The Dalles 41
Woodbridge 40
Hanoi 34
Helsinki 34
Cambridge 31
Orem 31
Rome 31
Amsterdam 24
Frankfurt am Main 24
Boston 23
Shanghai 23
Lauterbourg 21
Buffalo 20
Hefei 20
London 19
Chicago 18
Nuremberg 17
Redondo Beach 17
Dearborn 16
Guangzhou 16
Dublin 15
Montreal 15
Munich 15
Seoul 15
São Paulo 15
Toronto 15
Warsaw 13
Dong Ket 12
Milan 12
Pune 12
Chennai 11
Düsseldorf 11
Poplar 11
San Diego 11
Ann Arbor 10
Jacksonville 10
Brooklyn 9
Denver 9
New Delhi 9
Paris 9
Phoenix 9
Baghdad 8
Johannesburg 8
Lappeenranta 8
Mexico City 8
Rio de Janeiro 8
Stockholm 8
Tokyo 8
Da Nang 7
Haiphong 7
Manchester 7
Quito 7
Selargius 7
Turin 7
Belo Horizonte 6
Casablanca 6
Charlotte 6
Lahore 6
Medellín 6
Nanjing 6
Naples 6
Salt Lake City 6
Shenzhen 6
Wuhan 6
Atlanta 5
Bexley 5
Biên Hòa 5
Boulder 5
Brussels 5
Centro 5
Columbus 5
Guayaquil 5
Hangzhou 5
Hải Dương 5
Menlo Park 5
Olbia 5
Turku 5
Vienna 5
Zhengzhou 5
Augusta 4
Totale 35.615
Salva come PNG Salva come JPEG
Nome #
Clustered protocadherins methylation alterations in cancer 3.331
BRAF-mutant colorectal cancer, a different breed evolving 3.246
Molecular-biology-driven treatment for metastatic colorectal cancer 2.773
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples 2.702
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.376
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 2.145
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.126
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study 1.860
Immunotherapy and Cancer: The Multi-Omics Perspective 1.619
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.547
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.224
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 1.050
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 997
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 964
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 947
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 861
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 777
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 756
Uncovering key targets of success for immunotherapy in pancreatic cancer 728
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 651
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 606
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 510
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 441
CD44: A New Prognostic Marker in Colorectal Cancer? 276
A new prognostic score for biliary tract cancer: a multicenter experience 224
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 223
Early taxane exposure and neurotoxicity in breast cancer patients 219
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 218
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 208
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 198
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 190
Medical management of malignant bowel obstruction: our center experience 184
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 176
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 136
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 133
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 121
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 119
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 115
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 114
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 108
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 106
The role of metastasectomy in patients with early onset metastatic colorectal cancer 106
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 103
Integrating Artificial Intelligence into Breast Cancer Histopathology: Toward Improved Diagnosis and Prognosis 7
ARTIFICIAL INTELLIGENCE IN HISTOLOGICAL PROFILING OF HEPATOCELLULAR CARCINOMA: STATE OF THE ART 7
Totale 37.528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 0 0 235
2021/20222.350 196 120 63 131 142 126 101 128 218 252 312 561
2022/20233.974 319 654 564 307 286 357 175 306 275 290 290 151
2023/20245.431 233 115 136 192 296 560 565 2.165 169 229 374 397
2024/202510.559 3.026 3.284 1.030 1.034 484 701 448 51 122 109 76 194
2025/20264.175 329 255 372 376 300 298 796 387 235 383 276 168
Totale 37.528